Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Showing 20 of 0 results

Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT01467024
What this trial is testing

Evaluation of the MP Diagnostics HTLV Blot 2.4

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 600
Large-scale testing (Phase 3)Study completedNCT00002359
What this trial is testing

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

Who this might be right for
HIV Infections
The Immune Response Corporation 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00300573
What this trial is testing

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Incyte Corporation 250
Not applicableStudy completedNCT00849823
What this trial is testing

HIV Prevention Program for African American Teen Males

Who this might be right for
HIV InfectionsSexually Transmitted Infections
Richard Crosby 840
Large-scale testing (Phase 3)Study completedNCT00708162
What this trial is testing

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir

Who this might be right for
HIV Infection
Gilead Sciences 724
Early research (Phase 1)Study completedNCT05148754
What this trial is testing

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Who this might be right for
Covid19HIV-1-infection
Viriom 15
Large-scale testing (Phase 3)Study completedNCT01435018
What this trial is testing

Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 334
Large-scale testing (Phase 3)Ended earlyNCT00427297
What this trial is testing

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Who this might be right for
HIV Infections
University of Washington 34
Not applicableStudy completedNCT04638686
What this trial is testing

REal-Life Cohort With DOlutegravir + LAmivudina

Who this might be right for
HIV-1-infection
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 185
Testing effectiveness (Phase 2)Study completedNCT02212379
What this trial is testing

Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 170
Not applicableStudy completedNCT03772327
What this trial is testing

HIV Adherence Bottle Intervention Trial

Who this might be right for
HIV-1-infectionAdherence, Medication
Weill Medical College of Cornell University 63
Testing effectiveness (Phase 2)Study completedNCT00348673
What this trial is testing

A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

Who this might be right for
HIV-1
Pfizer 49
Large-scale testing (Phase 3)Study completedNCT00465205
What this trial is testing

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Who this might be right for
HIV InfectionsHerpes SimplexSexually Transmitted Diseases
University of Washington 20
Large-scale testing (Phase 3)Study completedNCT01792570
What this trial is testing

DRV/r + RPV QD: Efficacy and Toxicity Reduction

Who this might be right for
Human Immunodeficiency Virus
ASST Fatebenefratelli Sacco 37
Not applicableStudy completedNCT00002354
What this trial is testing

Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 540
Large-scale testing (Phase 3)WithdrawnNCT01337583
What this trial is testing

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc.
Large-scale testing (Phase 3)Study completedNCT00044577
What this trial is testing

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 166
Large-scale testing (Phase 3)Study completedNCT00021554
What this trial is testing

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 525
Not applicableUnknownNCT05690607
What this trial is testing

Small Volume Blood Testing Validity and Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs)

Who this might be right for
HIV InfectionsHepatitis B
Central and North West London NHS Foundation Trust 300
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation